Invasive strategy in patients with advanced diabetes and non-ST-segment elevation acute coronary syndrome. Angiographic findings and clinical follow-up. PREDICAR study results;Esrategia invasiva en pacientes con diabetes avanzada y síndrome coronario agudo sin elevación del segmento ST. Hallazgos angiográficos y evolución clínica. Resultados del estudio PREDICAR

Revista Espanola de Cardiologia

Volumn 59, Issue 4, 2006, Pages 321-328

  Sanchís, Juan ^a   González, Vicente Bertomeu ^a   Bodí, Vicent ^a   Núñez, Julio ^a   Lauwers, Catherine ^b   Ruiz Nodar, Juan M ^c   Díez, José L ^d   Bertolín, Vicente ^e   Casabán, Ernesto ^a   Navarro, Alejandro ^d   Frutos, Araceli ^c   Carratalá, Javier ^c   Liàcer, Angel ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL FRANCESC DE BORJA   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^d HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^e HOSPITAL DE SAGUNTO   (Spain)

Author keywords

Diabetes mellitus; Myocardial infarction; Revascularization; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY ARTERY SURGERY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE CARDIAC SURGERY; MORTALITY; MULTICENTER STUDY; PROGNOSIS; ST SEGMENT ELEVATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; ACUTE DISEASE; ELECTROCARDIOGRAPHY; HEART MUSCLE REVASCULARIZATION; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; SYNDROME;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; CORONARY ANGIOGRAPHY; DIABETES COMPLICATIONS; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; SYNDROME;

EID: 33744794292     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13087054     Document Type: Article

References (28)

1. FRISC II investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;354:708-15.
2. Wallentin L, Lagerqvist B, Usted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year alter an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 2000:356;9-16.
3. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87.
4. Fox KAA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TRD, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart foundation RITA 3 randomised trial. Lancet. 2002;360:743-51.
5. Bodí V, Sanchis J, Llácer A, Facial L, Núñez J, Pellicer M, et al. Estrategia invasiva en el síndrome coronario agudo sin elevación del segmento ST. De los grandes estudios al mundo real. Rev Esp Cardiol. 2004;57:143-50.
6. Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, et al. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: The FRISC II invasive troponin T electro-cardiogram substudy. Am Heart J. 2002;143:760-7.
7. Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, et al. ST depression in ECG at entry indicates severs coronary lesions and large benefits of an early invasive treatment strategy in unstable coronary artery disease. The FRISC II ECG substudy. Eur Heart J. 2002;23:41-9.
8. Cannon Ch, Bruanwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. N Engl J Med. 2001;345:1573-5.
9. Kornowski R, Mintz GS, Lansky AJ, Hong MY, Kent KM, Pichard AD, et al. Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol. 1998;81:1290-394.
10. Alonso JJ, Durán JM, Gimeno F, Ramos B, Serrador A, Fernández-Avilés F. Angioplastia coronaria en el paciente diabético. Situación actual y perspectivas futuras. Rev Esp Cardiol. 2002;55:1185-200.
11. Carson JL, Scholz PM, Chen AN, Peterson ED, Gold J, Schneider SH. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 2002;40:418-23.
12. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol. 1998;32:584-9.
13. Sanchis J, Bodí V, Llácer A, Facila L, Pellicer M, Bertomeu V, et al. Estratificación del riesgo de pacientes con dolor torácico agudo sin elevación del segmento ST en la puerta de urgencias. Rev Esp Cardiol. 2003;56:955-62.
14. Sanchis J, Bodí V, Núñez J, Bertomeu V, Gómez C, Bosch MJ, et al. New risk score for patientes with acute chest pain, non-ST-segment deviation and normal troponin concentrationss. A comparison with the TIMI risk score. J Am Coll Cardiol. 2005;46:443-9
15. Protocol for the bypass angioplasty revascularization investigation. Circulation. 1991;84 Suppl V:1-27.
16. Serrano Martínez M, Palacios M, Lezaun R. Monocyte chemoattractant protein-1 concentration in coronary sinus blood and severity of coronary disease Circulation. 2003;108:75.
17. Ottervanger JP, Armstrong P, Barnathan ES, Boersma E, Cooper JS, Ohman EM, et al. Association of revascularization with low mortality in non-ST elevation acute coronary syndrome. Eur Heart J. 2004;25:1494-501.
18. Martí H, Pérez-Bárcena J, Fiol M, Marrugat J, Navarro C, Aldasoro E, et al. Análisis de la asociación entre un tratamiento y un acontecimiento de interés en estudios observacionales utilizando la probabilidad de recibir el tratamiento (propensity score). Un ejemplo con la reperfusión miocárdica. Rev Esp Cardiol. 2005;58:126-36.
19. Morgan KP, Kapur A, Beatt KJ. Anatomy or coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart. 2003;90:732-8.
20. Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-I experience. J Am Coll Cardiol. 1996;28:1661-9.
21. Silva JA, Escobar A, Collins TJ, Ramee SR, White Ch. Unstable angina. A comparison of angioscopic findings between diabetic and non-diabetic patients. Circulation. 1995;92:1731-6.
22. Abaci A, Oguzhan A, Hahraman S, Eryol NK, Unal S, Arinc H, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999;99:2239-42.
23. Malberg K, Yusuf S, Gerstein HC, Brown J, Zhao H, Hunt D, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of OASIS registry. Circulation. 2000;102:1014-9.
24. Sanchis J, Bodí V, Llácer A, Facila L, Núñez J, Bertomeu V, et al. Usefulness of concomitant myoglobin and troponin elevation as biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes. Am J Cardiol. 2003;91:13-6.
25. Sanchis J, Bodí V, Llácer A, Núñez J, Consuegra L, Bosch MJ, et al. Risk stratification of patients with acute chest pain and normal troponin concentrations. Heart. 2005;91:1013-8.
26. Marso SP, Giorgi LV, Johnson WL, Huber KC, Laster SB, Shelton Ch J, et al. Diabetes mellitus is associated with a shift in the temporal risk profile of in-hospital death after percutaneous coronary intervention: an analysis of 25223 patients over 20 years. Am Heart J. 2003;145:270-7.
27. Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, et al. Randomized comparison od sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients. The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation. 2005;112:2175-83.
28. Moussa I, Leon MB, Baim D, O'Neill WW, Popma J, Buchbinder M, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients. A SIRIUS substudy. Circulation. 2004;109: 2273-8.